[1] Suknikhom W, Lertkhachonsuk R, Manchana T (2017). The Effects of Active Hexose Correlated Compound (AHCC) on Levels of CD4+ and CD8+ in Patients with Epithelial Ovarian Cancer or Peritoneal Cancer Receiving Platinum Based Chemotherapy. Asian Pac J Cancer Prev. 18(3):633-638. [2] Terakawa N, Matsui Y, Satoi S, Yanagimoto H, Takahashi K, Yamamoto T, Yamao J, Takai S, Kwon AH, Kamiyama Y. (2008). Immunological effect of active hexose correlated compound(AHCC) in healthy volunteers: a double-blind, placebo-controlled trial. Nutrition and cancer, 60(5), 643-651. [3] Smith, Judith & Gaikwad, Anjali & Mathew, Lata & Rech, Barbara & Faro, Jonathan & Lucci, Joseph & Bai, Yu & Olsen, Randall & Byrd, Teresa. (2022). AHCC® Supplementation to Support Immune Function to Clear Persistent Human Papillomavirus Infections. Frontiers in Oncology. 12. 881902. [4] Haabeth, Ole Audun Werner; Tveita, Anders Aune; Fauskanger, Marte; Schjesvold, Fredrik; Lorvik, Kristina Berg; Hofgaard, Peter O.; Omholt, Hilde; Munthe, Ludvig A.; Dembic, Zlatko; Corthay, Alexandre; Bogen, Bjarne (2014). How Do CD4+ T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?. Frontiers in Immunology, 5. [5] Ahrends, Tomasz; Borst, Jannie (2018). The opposing roles of CD4+ T cells in anti-tumour immunity. Immunology, 154(4):582–92. [6] Shin, Min Sun; Park, Hong-Jai; Maeda, Takahiro; Nishioka, Hiroshi; Fujii, Hajime; Kang, Insoo (2019). The Effects of AHCC®, a Standardized Extract of Cultured Lentinura edodes Mycelia, on Natural Killer and T Cells in Health and Disease: Reviews on Human and Animal Studies. Journal of Immunology Research, 1–7. |